US Patent Issued to HARBOUR BIOMED (SUZHOU) on Aug. 11 for "Antibody targeting BCMA, bispecific antibody, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,755, issued on Aug. 11, was assigned to HARBOUR BIOMED (SUZHOU) Co. LTD. (Suzhou, China).

"Antibody targeting BCMA, bispecific antibody, and use thereof" was invented by Lei Shi (Suzhou, China), Xuekun Zhang (Suzhou, China), Yun He (Suzhou, China), Jianxun Zhao (Suzhou, China), Wei Zhou (Suzhou, China), Fei Chen (Suzhou, China), Xiangyang Tan (Suzhou, China) and Yiping Rong (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an antibody targeting BCMA, a bispecific antibody targeting BCMA and CD3, and applications thereof. The antibody targeting BCMA comprises two heavy chain variable regions, the heavy chain variable regions ...